BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Scalera A, Di Minno MND, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(33): 5402-5420 [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402]
URL: https://www.wjgnet.com/2220-3214/full/v19/i33/5402.htm
Number Citing Articles
1
Xiangxue Ma, Xiaoge Wang, Nan Kang, Ting Chen, Haijie Ji, Lin Lv, Xiaolan Yin, Yaxin Tian, Rui Zheng, Yuanzhi Duan, Fengyun Wang, Xudong Tang. The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome RatsEvidence-Based Complementary and Alternative Medicine 2017; 2017: 1 doi: 10.1155/2017/9086034
2
Huw Purssell, Peter J Whorwell, Varinder S Athwal, Dipesh H Vasant. Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?World Journal of Hepatology 2021; 13(12): 1816-1827 doi: 10.4254/wjh.v13.i12.1816
3
Shanshan Wu, Changzheng Yuan, Zhirong Yang, Si Liu, Qian Zhang, Shutian Zhang, Shengtao Zhu. Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort studyBMC Medicine 2022; 20(1) doi: 10.1186/s12916-022-02460-8
4
Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver diseaseComputers in Biology and Medicine 2021; 131: 104243 doi: 10.1016/j.compbiomed.2021.104243
5
Divna Popović, Stefan Rošić, Snežana Lukić. Incidence of different types of irritable bowel syndrome in patients with nonalcoholic fatty liverMedicinski podmladak 2022; 73(2): 6 doi: 10.5937/mp73-33427
6
Smaragda Ntona, Apostolis Papaefthymiou, Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, Marina Boziki, Stergios A. Polyzos, Maria Tzitiridou, Dimitrios Chatzopoulos, Tharshika Thavayogarajah, Ioanna Gkolia, Georgios Ntonas, Elisabeth Vardaka, Michael Doulberis. Impact of nonalcoholic fatty liver disease-related metabolic state on depressionNeurochemistry International 2023; 163: 105484 doi: 10.1016/j.neuint.2023.105484
7
Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic reviewWorld Journal of Hepatology 2023; 15(7): 925-938 doi: 10.4254/wjh.v15.i7.925
8
Sharif Yassin, Noa Sori, Ophir Gilad, Mati Shnell, Relly Richer, Nir Bar, Yishai Ron, Nathaniel Aviv Cohen, Subhi Abu-Abeid, Danit Dayan, Shai Meron Eldar, Shira Zelber-Sagi, Sigal Fishman. Functional bowel disorders among bariatric surgery candidates before and after surgery: A prospective cohort studyInternational Journal of Gastrointestinal Intervention 2024; 13(1): 16 doi: 10.18528/ijgii230045
9
Lissa Franco, Michelle Jones-Pauley, Omar Tamimi, Leila Neshatian, Duc Nguyen, Edward Graviss, Eamonn MM Quigley, David Victor. Irritable Bowel Syndrome Symptoms in Nonalcoholic Fatty Liver Disease Patients Are an Indicator of Depression and AnxietyJournal of Clinical Gastroenterology 2023; 57(10): 1016 doi: 10.1097/MCG.0000000000001770
10
M. K. Srilekha, S. N. Deepa, N. R. Shanker, M. Priya. Human Fatty Liver Volume Measurement Device Using Nano Graphene Polyvinyl SensorIEEE Sensors Journal 2023; 23(20): 25390 doi: 10.1109/JSEN.2023.3308769
11
Peyman Arasteh, Najmeh Maharlouei, Seyed Sajjad Eghbali, Mitra Amini, Kamran B. Lankarani, Reza Malekzadeh. A Comprehensive Look at Irritable Bowel Syndrome and its Associated Factors Considering the Rome IV Criteria: A Penalized Smoothly Clipped Absolute Deviation Regression Approach in the Pars Cohort StudyMiddle East Journal of Digestive Diseases 2018; 10(3): 149 doi: 10.15171/mejdd.2018.104
12
Alejandra de Moreno de LeBlanc, Jean Guy LeBlanc. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applicationsWorld Journal of Gastroenterology 2014; 20(44): 16518-16528 doi: 10.3748/wjg.v20.i44.16518
13
Huw Purssell, Lucy Bennett, Oliver Street, Karen Piper Hanley, Neil Hanley, Dipesh H. Vasant, Varinder S. Athwal. The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional studyScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35774-5
14
Lulu Deng, Zihao Ou, Dongquan Huang, Chong Li, Zhi Lu, Wanting Liu, Feifan Wu, Caihong Nong, Jie Gao, Yongzheng Peng. Diverse effects of different Akkermansia muciniphila genotypes on Brown adipose tissue inflammation and whitening in a high-fat-diet murine modelMicrobial Pathogenesis 2020; 147: 104353 doi: 10.1016/j.micpath.2020.104353
15
Paola Dongiovanni, Annalisa Crudele, Nadia Panera, Ilaria Romito, Marica Meroni, Cristiano De Stefanis, Alessia Palma, Donatella Comparcola, Anna Ludovica Fracanzani, Luca Miele, Luca Valenti, Valerio Nobili, Anna Alisi. β-Klotho gene variation is associated with liver damage in children with NAFLDJournal of Hepatology 2020; 72(3): 411 doi: 10.1016/j.jhep.2019.10.011
16
Varun Chandrashekaran, Ratanesh K. Seth, Diptadip Dattaroy, Firas Alhasson, Jacek Ziolenka, James Carson, Franklin G. Berger, Balaraman Kalyanaraman, Anna Mae Diehl, Saurabh Chatterjee. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver diseaseRedox Biology 2017; 13: 8 doi: 10.1016/j.redox.2017.05.005
17
Ai Zhao, Mei-Chen Wang, Ignatius Man-Yau Szeto, Li-Ping Meng, Yan Wang, Ting Li, Yu-Mei Zhang. Gastrointestinal discomforts and dietary intake in Chinese urban elders: A cross-sectional study in eight cities of ChinaWorld Journal of Gastroenterology 2019; 25(45): 6681-6692 doi: 10.3748/wjg.v25.i45.6681
18
Peng Zhang, Ying Ma, Zheng Wang, Decai Tang. The Effect and Mechanism of Sancao Lichang Decoction on Diarrhea- Predominant Irritable Bowel Syndrome by Regulating Tlr4/Myd88/Nf-Κb PathwayCombinatorial Chemistry & High Throughput Screening 2023; 26(13): 2372 doi: 10.2174/1386207326666230301104248
19
Xuguang Hu, Xiaojun Zhang, Bin Han, Weijian Bei. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptorBMC Complementary and Alternative Medicine 2013; 13(1) doi: 10.1186/1472-6882-13-246
20
Martin Aasbrenn, Ingvild Høgestøl, Inger Eribe, Jon Kristinsson, Stian Lydersen, Tom Mala, Per G. Farup. Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional studyBMC Obesity 2017; 4(1) doi: 10.1186/s40608-017-0159-z
21
Matteo Nicola Dario Di Minno, Alessandro Di Minno, Pasquale Ambrosino, Paola Songia, Elena Tremoli, Paolo Poggio. Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosisInternational Journal of Cardiology 2016; 217: 1 doi: 10.1016/j.ijcard.2016.04.162